CME icon

CME Group

276.99 USD
+4.63
1.70%
At close Apr 30, 3:59 PM EDT
After hours
277.08
+0.09
0.03%
1 day
1.70%
5 days
5.93%
1 month
4.41%
3 months
17.41%
6 months
21.88%
Year to date
19.02%
1 year
32.13%
5 years
55.43%
10 years
204.69%
 

About: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Employees: 3,760

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

168% more first-time investments, than exits

New positions opened: 193 | Existing positions closed: 72

53% more call options, than puts

Call options by funds: $492M | Put options by funds: $322M

39% more funds holding in top 10

Funds holding in top 10: 38 [Q3] → 53 (+15) [Q4]

21% more repeat investments, than reductions

Existing positions increased: 586 | Existing positions reduced: 483

9% more capital invested

Capital invested by funds: $68.2B [Q3] → $74.4B (+$6.21B) [Q4]

7% more funds holding

Funds holding: 1,372 [Q3] → 1,464 (+92) [Q4]

2.13% more ownership

Funds ownership: 85.91% [Q3] → 88.04% (+2.13%) [Q4]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$211
24%
downside
Avg. target
$271
2%
downside
High target
$305
10%
upside

10 analyst ratings

positive
50%
neutral
30%
negative
20%
UBS
Alex Kramm
61% 1-year accuracy
11 / 18 met price target
10%upside
$305
Buy
Maintained
25 Apr 2025
Morgan Stanley
Mike Cyprys
50% 1-year accuracy
4 / 8 met price target
10%upside
$304
Overweight
Maintained
24 Apr 2025
Keefe, Bruyette & Woods
Kyle Voigt
63% 1-year accuracy
19 / 30 met price target
1%downside
$273
Market Perform
Maintained
24 Apr 2025
JP Morgan
Kenneth Worthington
57% 1-year accuracy
17 / 30 met price target
24%downside
$211
Underweight
Maintained
24 Apr 2025
Barclays
Benjamin Budish
64% 1-year accuracy
85 / 133 met price target
2%upside
$283
Equal-Weight
Maintained
23 Apr 2025

Financial journalist opinion

Based on 38 articles about CME published over the past 30 days

Neutral
CNBC Television
2 hours ago
Final Trades: Berkshire Hathaway, Vertex Pharma, S&P Global and CME Group
Final Trades are in! The Investment Committee reveals their top picks to close out the day—don't miss it!
Final Trades: Berkshire Hathaway, Vertex Pharma, S&P Global and CME Group
Positive
Zacks Investment Research
3 hours ago
CME Group (CME) Is Up 1.44% in One Week: What You Should Know
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
CME Group (CME) Is Up 1.44% in One Week: What You Should Know
Positive
Seeking Alpha
7 hours ago
CME Group: Expect Generous Dividends This Year
CME Group thrives on market volatility, earning revenue on every trade, making it resilient in both good and bad times. CME's niche in the derivatives market, international expansion, and product innovation drive growth, especially during uncertain times. Strong financials, including solid profit margins and high dividend payouts, make CME an attractive investment for income-focused investors.
CME Group: Expect Generous Dividends This Year
Neutral
Seeking Alpha
3 days ago
CME: More Market Volatility Equals More Demands - Initiating With Strong Buy
Initiating a 'Strong Buy' rating for CME with a fair value of $301 per share due to increased demand for hedging amid economic uncertainty and market volatility. CME's diverse product offerings and strong trading volume growth, particularly in interest rate options/futures, equity, FX, energy, and commodities, support its robust business model. CME's high operating margin, capex-light business model, and strategic use of Google Cloud enhance profitability and operational efficiency.
CME: More Market Volatility Equals More Demands - Initiating With Strong Buy
Positive
InvestorPlace
3 days ago
3 Stocks to Buy Before the May 7 Catalyst
Tom Yeung here with your Sunday Digest.  In the 1990s, my father moved our family to a new overseas “Florida-style” housing development.
3 Stocks to Buy Before the May 7 Catalyst
Positive
Zacks Investment Research
6 days ago
Top Cryptocurrency Stocks You Should Buy for a Healthy Portfolio
Here, we pick three stocks, CME, BTCM and CAN, which are well-poised to benefit from the growing proliferation of Bitcoin and other cryptocurrencies.
Top Cryptocurrency Stocks You Should Buy for a Healthy Portfolio
Positive
Reuters
6 days ago
Derivatives exchange CME set to launch XRP futures in crypto push
CME Group will launch futures contracts tied to the XRP cryptocurrency next month, the derivatives exchange said on Thursday, aiming to tap into the growing interest in tokens other than bitcoin and ether.
Derivatives exchange CME set to launch XRP futures in crypto push
Neutral
PRNewsWire
6 days ago
CME Group to Expand Crypto Derivatives Suite with Launch of XRP Futures
CHICAGO , April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch XRP futures on May 19, pending regulatory review. Market participants will have the choice to trade both a micro-sized contract (2,500 XRP) and a larger-sized contract (50,000 XRP).
CME Group to Expand Crypto Derivatives Suite with Launch of XRP Futures
Neutral
CNBC Television
6 days ago
'Whole host of other factors' outside of tariffs driving volatility, says CME Group's Terry Duffy
CME Group CEO Terry Duffy joins 'Fast Money' to talk market volatility surge, latest earning, and more.
'Whole host of other factors' outside of tariffs driving volatility, says CME Group's Terry Duffy
Positive
Zacks Investment Research
1 week ago
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag
CME Group's Q1 results reflect improved revenues and increased volatility that aided volumes.
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag
Charts implemented using Lightweight Charts™